Clinical Trial Update: Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study [Phase 3]

View source ↗

Summary

A Phase III randomized trial comparing Amonafide (AS1413) with Cytarabine to Daunorubicin with Cytarabine in patients with secondary acute myeloid leukemia (ACC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Amonafide (AS1413) (amonafide)
• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)

Snippet

Sponsor: Antisoma Research | Conditions: Secondary Acute Myeloid Leukemia (Secondary AML, sAML) | Phase 3 | Status: UNKNOWN